NERM
MJN

New England Research & Management’s Mead Johnson Nutrition Company MJN Stock Holding History

New England Research & Management’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-4,975
Closed -$350K – 182
2015
Q3 		$350K Hold
4,975
– – 0.33% 113
2015
Q2 		$449K Buy
+4,975
New +$480K 0.37% 101

Other funds holding MJN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

New England Research & Management's MJN Position: Q4 2015 in Review

New England Research & Management sold out of Mead Johnson Nutrition Company (MJN) in Q4 2015, closing a stake of 4,975 shares — an estimated $350K sold.

New England Research & Management first reported a position in MJN in Q2 2015 and held it in 2 quarters. The position peaked at $449K in Q2 2015. 549 funds tracked by Wall St. Rank hold MJN as of Q4 2015.

  • New England Research & Management reported no remaining Mead Johnson Nutrition Company position as of Q4 2015 after selling out during the quarter.
  • New England Research & Management sold 4,975 Mead Johnson Nutrition Company shares in Q4 2015, an estimated $350K.
  • New England Research & Management first reported a position in Mead Johnson Nutrition Company in Q2 2015 and held it in 2 quarters.
  • New England Research & Management's Mead Johnson Nutrition Company position peaked at $449K in Q2 2015.
  • 549 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q4 2015.

Based on New England Research & Management's 13F filing for Q4 2015, filed 8 Jan 2016.